Corosolic Acid Inhibits Hepatocellular Carcinoma Cell Migration by Targeting the VEGFR2/Src/FAK Pathway

Chung-Yu Ku1, Ying-Ren Wang1, Hsuan-Yuan Lin2

  • 1Institute of Biochemistry and Molecular Biology, College of Medicine, National Taiwan University, Taipei, 100, Taiwan.

Plos One
|May 16, 2015
PubMed

Insights

Corosolic acid (CA) from Actinidia chinensis inhibits hepatocellular carcinoma (HCC) growth by targeting VEGFR2. CA shows synergistic effects with sorafenib, offering a potential therapeutic strategy for aggressive HCC.

Area of Science:

  • Oncology
  • Molecular Biology
  • Pharmacology

Background:

  • Hepatocellular carcinoma (HCC) treatment often involves targeting vascular endothelial growth factor receptor 2 (VEGFR2).
  • Identifying novel therapeutic agents for HCC is crucial for improving patient outcomes.

Purpose of the Study:

  • To investigate the anti-cancer effects and molecular mechanisms of corosolic acid (CA) on HCC cells.
  • To evaluate CA's potential as a therapeutic or adjuvant strategy for HCC.

Main Methods:

  • In vitro kinase assays to assess CA's interaction with VEGFR2 ATP binding pocket.
  • Cellular assays to analyze the VEGFR2/Src/FAK/cdc42 signaling pathway and cell migration.
  • In vivo studies using a mouse model to evaluate CA's efficacy on tumor growth.
  • Combination studies with sorafenib to assess synergistic effects.

Main Results:

  • Corosolic acid (CA) directly inhibits VEGFR2 kinase activity.
  • CA down-regulates the VEGFR2/Src/FAK/cdc42 axis, reducing F-actin formation and cell migration in vitro.
  • CA demonstrated effective dose-dependent inhibition of tumor growth in vivo (5 mg/kg/day).
  • CA exhibited a synergistic effect with sorafenib across various concentrations.

Conclusions:

  • Corosolic acid (CA) possesses significant anti-cancer properties against HCC by inhibiting VEGFR2 signaling.
  • CA's ability to disrupt the VEGFR2/Src/FAK/cdc42 pathway and reduce tumor growth suggests its therapeutic potential.
  • CA may serve as a valuable therapeutic or adjuvant agent for patients with aggressive HCC, potentially in combination with existing treatments like sorafenib.

Related Concept Videos

Cancer Cell Migration through Invadopodia01:35

Cancer Cell Migration through Invadopodia

Invadosome is a broad category of cell surface structures with proteolytic activity that  degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
3.5K
Cell Migration01:19

Cell Migration

Cell migration is a process by which the cells move from one location to another, playing an essential role in embryological development, repair and regeneration, immune response, and metastasis. Cells migrate in response to chemical or mechanical signals generated by specific organs or tissues. The overall mechanism includes three steps - polarization, protrusion, and release. Polarization involves the formation of a distinct cell front and rear, which determines the direction of movement.
7.5K
Cell Migration01:09

Cell Migration

Cell migration, the process by which cells move from one location to another, is essential for the proper development and viability of organisms throughout their life. When cells are not able to migrate properly to their ordained locations, various disorders may occur. For example, disruption in cell migration causes chronic inflammatory diseases such as arthritis.
19.2K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.2K
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

5.7K
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
3.8K